A survey from APhA reported that the majority of pharmacists plan to or have received a COVID-19 vaccine.
The vast majority of pharmacists plan to or have received a coronavirus disease 2019 (COVID-19) vaccine, according to a survey of 570 pharmacists conducted last week by the American Pharmacists Association (APhA).1
Of these pharmacists, 51% have received 1 dose, 10% have received 2 doses, and 31% plan to get it as soon as it is available.
Moreover, 95% of respondents indicated they are comfortable addressing patients’ concerns about the vaccine. Vaccine hesitancy has been identified as a foreseeable roadblock to widespread immunization against COVID-19, but pharmacists can help alleviate patient concerns.
Related: ASHP Urges Biden to Use Federal Resources, Expand Workforce for COVID-19 Vaccinations
A poll conducted by The Associated Press-NORC Center of Public Affairs Research in May 2020 showed that only half of Americans are willing to receive the vaccine.2 A more recent Kaiser Family Foundation (KFF) survey suggested an increase in the share of the public (71%) who said they would definitely or probably get the COVID-19 vaccine, up from 63% in a September survey.3 However, approximately 1 quarter of the public remains vaccine hesitant.3
“The rising rates of pharmacists’ confidence in the vaccine and their planned participation in vaccination activities demonstrates that pharmacists are ready, willing, and able to protect Americans against the coronavirus,” Scott J. Knoer, PharmD, MS, FASHP, executive vice president and chief executive officer of APhA, said in a statement. “Approximately 400,000 pharmacists, pharmacy technicians, and pharmacy interns have been trained for precisely this moment, and we’re ready to do the job.”
Additionally, 41% of pharmacists surveyed reported they were already administering the vaccine, 38% said they would be able to administer it as soon as it is available, and 17% were preparing to administer the vaccinations and would participate in future phases of the vaccine delivery program. Seventy-nine percent of pharmacists said staffing in their pharmacy practice is adequate to offer the vaccine.
APhA has conducted 3 surveys about the COVID-19 vaccine since September 2020. In each successive survey, an increasing number of pharmacists said they planned to be immunized, manage the logistics of handling the vaccine, and would administer it to their patients.
References
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
Pfizer Announces Positive Top-Line Data for Abrysvo Immunization in Adults Aged 18 to 59 Years
April 9th 2024Abrysvo is currently approved to treat RSV-associated lower respiratory tract disease in adults aged 60 years and older, and in infants through the immunization of pregnant individuals.